The New York Gaming Commission (NYGC), during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.

The NYGC, which oversees horse racing in the state, is currently considering uniform model drug rules approved by the Racing Medication and Testing Consortium (RMTC) and adopted by the Association of Racing Commissioners International (RCI). Many states in the Mid-Atlantic region have enacted the rules or are in the process of adopting them.

Concerns over withdrawal times and threshold levels for clenbuterol and corticosteroids led the United States Trotting Association (USTA) to leave the RMTC in late September 2013 and to publicly oppose the rules adopted by RCI. Standardbred leaders have repeatedly said current regulations are effective for harness horses.

"We’ve used (the medications) for 10 years or more, and we don’t have a problem with them," USTA president Phil Langley told the NYGC. "Our breed is just so durable

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.